MEDVi
MEDVi is a telehealth platform offering weight loss programs primarily based on GLP-1 antagonist medications. It’s a fully online solution for overweight individuals to sign up for monthly medication prescriptions and support from medical practitioners. It has helped over 500,000 patients so far. The company mainly provides compounded medication, which is a custom, small-batch medication with the same active ingredient as the brand-name alternative. MEDVi offers both injectable and oral forms of semaglutide and tirzepatide, two well-known and extensively tested medications for weight loss. It also provides the brand name version of the medications, Ozempic® and Wegovy®, subject to availability. The weight loss program takes a personalized approach, with medication and other recommendations from a qualified, licensed healthcare provider, according to the current weight, target weight, health conditions, and medical history.